Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer
22 September 2022 - 10:30PM
DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq:
XRAY) today announced that Glenn Coleman has been appointed
Executive Vice President and Chief Financial Officer, effective
September 26, 2022. He succeeds Barbara Bodem, who has served as
Interim Chief Financial Officer since May 2022. Ms. Bodem will
remain with the company and continue to serve as an advisor to Mr.
Coleman until October 24, 2022.
Mr. Coleman brings 30 years of financial management expertise to
Dentsply Sirona. He joins the Company from Integra Lifesciences
Holdings Corporation (“Integra”), where he most recently served as
Executive Vice President and Chief Operating Officer and previously
held the role of Chief Financial Officer. Prior to Integra, Mr.
Coleman held numerous financial management positions at leading
global businesses, including Curtiss-Wright Corporation and
Alcatel-Lucent.
Simon Campion, Chief Executive Officer of Dentsply Sirona, said,
“We are pleased to have Glenn join us in the CFO role. He is a
transformational leader with a strong history of driving value
creation and sustainable growth. Over the course of his career, he
has overseen financial and operational functions across several
geographies and industries, including healthcare. Glenn, like me,
is a high-integrity leader who shares our commitment to
accountability, operational rigor, discipline, and execution. I
have no doubts that he will be a great thought partner for me and
the other members of the leadership team. Glenn’s leadership will
be instrumental as we move forward with the previously announced
review of the Company’s business and operations including
competitive positioning and portfolio, margin enhancement
opportunities, and capital structure.”
Mr. Coleman said, “I’m excited to join Dentsply Sirona as the
Company prepares to enter its next chapter. I look forward to
working with Simon and rest of the team to bring greater focus and
discipline to our execution, advance our financial, operational,
and strategic goals, and ultimately deliver long-term growth and
value creation.”
Mr. Campion continued, “On behalf of the Company, I would like
to express our gratitude to Barbara for her service as Interim CFO.
During her tenure, Barbara enhanced key financial processes, helped
build improved management systems, and advanced our top operational
priorities. We look forward to continuing to benefit from her
exceptional skill and leadership during the transition.”
About Glenn Coleman
Mr. Coleman previously served as Executive Vice
President & Chief Operating Officer at Integra Lifesciences
Holdings Corporation; a role held since 2019. As Chief Operating
Officer, Mr. Coleman led operations and most of Integra’s talent
force, including clinical, R&D, manufacturing, and quality
functions while also leading the international team. Mr. Coleman
was previously Integra’s Chief Financial Officer overseeing the
finance department, including accounting and financial reporting,
budgeting, internal audit, tax, treasury, investor relations, and
information technology while also leading the international
business. Prior to Integra, Mr. Coleman spent 25 years in financial
management positions with leading global businesses, including
Curtiss-Wright Corporation and Alcatel-Lucent, and began his career
at PricewaterhouseCoopers LLP.
Mr. Coleman earned a Bachelor of Science from Montclair State
University and has been a CPA in New Jersey for more than 25
years.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of
professional dental products and technologies, with over a century
of innovation and service to the dental industry and patients
worldwide. Dentsply Sirona develops, manufactures, and markets a
comprehensive solutions offering including dental and oral health
products as well as other consumable medical devices under a strong
portfolio of world class brands. Dentsply Sirona’s products provide
innovative, high-quality and effective solutions to advance patient
care and deliver better and safer dental care. Dentsply Sirona’s
headquarters is located in Charlotte, North Carolina. The Company’s
shares are listed in the United States on Nasdaq under the symbol
XRAY. Visit www.dentsplysirona.com for more information about
Dentsply Sirona and its products.
Contact Information
Investors:Andrea DaleyVP, Investor
Relations+1-704-805-1293InvestorRelations@dentsplysirona.com
Press: Marion Par-Weixlberger VP, Corporate
Communications and PR+43 676
848414588 marion.par-weixlberger@dentsplysirona.com
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024